Smith & Nephew misses on fourth-quarter revenue as developed markets slow

(Reuters) - British medical products maker Smith & Nephew fell short of analysts' expectations for fourth-quarter revenue on Thursday, as growth in established markets including the United States slowed and the company was hurt by a stronger dollar.

Revenue edged up 1.3 percent to $1.29 billion, short of analysts' average forecast of $1.30 billion, according to a company-provided consensus http://www.smith-nephew.com/investor-centre/reporting/analyst-consensus.

The company's operating profit for the year also fell to $863 million from $934 million a year earlier.

(Reporting by Pushkala Aripaka in Bengaluru; editing by Patrick Graham)